TGA approves HRT patch alternatives The ongoing short supply of hormone replacement therapy patches has resulted in the approval of a range of overseas alternatives.
Study urges tailored use of MHT Shared decision-making and an individualised approach are key when it comes to MHT, but there is an ‘urgent need’ for more research.
Puberty blocker pause leaves patients ‘languishing’ GPs caring for young trans people in Queensland will face ‘a very hard time’ following a pause on hormone therapy for under 18s.
Examining the pros and cons of semaglutide A new study finds lowered risk of 42 health outcomes and increased risk of 19 for people using GLP-1RAs, highlighting the ‘far-reaching potential’ of the drugs.
Do GPs know enough about this ‘debilitating’ disorder? Experts agree there has been a dire lack of education around PMDD, but GPs could be in the ‘ideal situation’ to help.
TGA renews calls to limit new HRT patch prescriptions The reoccurring shortages are now expected to last until the end of 2025, raising concerns from GPs about how to support their patients long-term.
GLP-1 receptor agonists linked to kidney failure prevention: Study It found the diabetes and weight-loss drugs can reduce deterioration regardless of diabetes status, but supply remains an issue.
Tool developed to help GPs manage menopause The MenoPROMPT assessment program has been developed by a team of Australian experts to help GPs better manage menopause.
Improving menopause diagnosis experiences Once taboo, menopause is now at the centre of several guides and toolkits, and experts are calling on GPs to read up on best practice treatment.
Lack of safety data prompts guidance on oestrogen therapy A summary of evidence is out for prescribing oestrogen treatments for the estimated 75% of breast cancer patients who develop genitourinary symptoms.